EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.6.4.B7 | Acquired Immunodeficiency Syndrome |
22316482 |
Monoclonal antibodies against the Escherichia coli DNA repair protein RadA/Sms. |
causal interaction
unassigned |
2
0 |
| 3.6.4.B7 | Acquired Immunodeficiency Syndrome |
26627254 |
Rad51 recombinase prevents Mre11 nuclease-dependent degradation and excessive PrimPol-mediated elongation of nascent DNA after UV irradiation. |
causal interaction
unassigned |
2
0 |
| 3.6.4.B7 | Adenocarcinoma |
10851081 |
DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
1
3
0 |
| 3.6.4.B7 | Adenocarcinoma |
11935313 |
Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigen. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
4
0 |
| 3.6.4.B7 | Adenocarcinoma |
15956972 |
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
4
1 |
| 3.6.4.B7 | Adenocarcinoma |
19176491 |
Increased Expression of BRCA2 and RAD51 in Lymph Node Metastases of Canine Mammary Adenocarcinomas. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
2
3 |
| 3.6.4.B7 | Adenocarcinoma |
20197614 |
[Expression of RAD51 and MAX in pancreatic cancer rats.] |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
4
0 |
| 3.6.4.B7 | Adenocarcinoma |
21107697 |
Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
3
3
0 |
| 3.6.4.B7 | Adenocarcinoma |
22399496 |
Targeting PI3K and RAD51 in Barrett's Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth. |
causal interaction
ongoing research
unassigned |
4
4
0 |
| 3.6.4.B7 | Adenocarcinoma |
23065657 |
RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
1 |
